Home
About
Overview
Sharing Data
ORCID
Help
History (78)
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Private Equity's Game Plan and Why it Should Matter to Us.
Classical lissencephaly syndromes: does the face reflect the brain?
Editors' Note: IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke.
Overcoming immunological barriers in regenerative medicine.
See All 78 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overcoming immunological barriers in regenerative medicine.
Overcoming immunological barriers in regenerative medicine. Nat Biotechnol. 2014 Aug; 32(8):786-94.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Cell- and Tissue-Based Therapy
Chimerism
Hematopoietic Stem Cell Transplantation
Humans
Immune Tolerance
Immunosuppressive Agents
Organ Transplantation
Regenerative Medicine
Tumor Escape
authors with profiles
Jeffrey Hubbell